Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-26T07:00:50.579Z Has data issue: false hasContentIssue false
  • English
  • Français

Hepatitis B Prevention Strategies Among Pediatric Hemodialysis Centers

Published online by Cambridge University Press:  02 January 2015

Michelle Toma  and
Malliswari Challapalli
Michelle Toma
Affiliation:
Department of Pediatrics, Ronald McDonald Children's Hospital, Loyola University Medical Center, Maywood, Illinois
Malliswari Challapalli*
Affiliation:
Department of Pediatrics, Ronald McDonald Children's Hospital, Loyola University Medical Center, Maywood, Illinois
*
Ronald McDonald Children's Hospital of Loyola University Medical Center, Department of Pediatrics, Section of Pediatric Infectious Diseases, 2160 S 1st Ave, Bldg 105, Room 3331, Maywood, IL 60153
Get access Rights & Permissions [Opens in a new window]

Abstract

We surveyed pediatric hemodialysis centers (PHDCs) concerning their hepatitis B virus (HBV) prevention strategies. One hundred thirty-one patients were being dialyzed in these PHDCs in December 1996. Although all centers immunized HBV-susceptible hemodialysis patients and had infection control policies to curtail the spread of HBV infection, most centers were not in compliance with all of the Centers for Disease Control and Prevention recommendations for isolating hepatitis B surface antigen-positive patients.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 22 , Issue 2 , February 2001 , pp. 113 - 115
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control and Prevention. Outbreaks of hepatitis B virus infection among hemodialysis patients—California, Nebraska, and Texas, 1994. MMWR 1996;45:285–289.Google Scholar
2. Centers for Disease Control and Prevention. Hepatitis-control measures for hepatitis B in dialysis centers. In: Hepatitis Surveillance Report No. 41. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC; 1977:12–17.Google Scholar
3. Centers for Disease Control and Prevention. Update: Universal Precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR 1988;37:377-382, 387–388.Google Scholar
4. Tokars, JI, Alter, MJ, Favero, MS, Moyer, LA, Miller, E, Bland, LA. National surveillance of dialysis associated diseases in the United States, 1993. ASAIO J 1996;42:219–229.Google Scholar
5. Niu, MT, Penberthy, LT, Alter, JF, Armstrong, CW, Miller, GB, Hadler, SC. Hemodialysis-associated hepatitis B: report of an outbreak. Dialysis & Transplantation 1989;18:542-546, 555.Google Scholar
6. Alter, JF, Ahtone, J, Maynard, JE. Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit. Ann Intern Med 1983;99:330–333.Google Scholar
7. Centers for Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination—recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-13):1–25.Google Scholar